TSK LABORATORY, JAPAN

TSK Laboratory specializes in single-use medical devices, specifically hypodermic needles and tissue injection cannulas. These products are designed for clinical procedures, including subcutaneous or intramuscular injections. Examples include sterile disposable cannulas and hypodermic needles, such as those branded STERiJECT™ and STERiGLIDE™.

TSK Laboratory is based in the United States, though it originates from Japan. The company’s devices are manufactured and intended for use in the US market, where they are subject to FDA regulations.

TSK Laboratory’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and compliance tracking for medical devices authorized for use in the United States.

TSK Laboratory’s devices fall under two FDA classification categories: Class I and Class II. Class I devices generally pose minimal risk and require less regulatory oversight, while Class II devices involve moderate risk and may require special controls to ensure safety and effectiveness. The classification depends on factors like the device’s intended use and potential risks.

TSK Laboratory’s Class II devices are categorized as such because they involve a higher level of risk compared to Class I products. For example, tissue injection cannulas may carry a slightly greater risk of complications (e.g., tissue damage or infection) than basic hypodermic needles, necessitating additional regulatory scrutiny to ensure proper design, manufacturing, and performance controls.